Skip to Content
Search Menu

COVID-19 Is Safe and Effective Among IBD Patients

During the COVID-19 pandemic, there was a lot of concern, especially among patients, whether they should be vaccinated or not and, if so, whether they should continue with their medication. This study concludes that COVID-19 is safe and effective among IBD patients, and following vaccination, most complications are minor and negligible, as explained in this MEDtalk by Dr. Pezhman Alavinejad.
Pezhman Alavinejad

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Thea Wiken

Vedolizumab and Ustekinumab as Treatment for Patients with Ulcerative Colitis

/ Thea Helm Wiken
ECCO24Ulcerative colitis Play the Video 5:52

Reproductive Safety of Novel Small Molecules in IBD

/ Christian Philipp Selinger
IBDPregnancy Play the Video 5:00

Managing Risks with Newer Oral Small Molecules in Patients with IBD

/ Parakkal Deepak
IBDJAK-inhibitors Play the Video 10:38

Increased Incidence of Comorbid Diseases 10 years Prior to IBD Diagnosis

/ Anthony C. Ebert
ECCO24IBD Play the Video 6:47
Gorm Roager Madsen

Periodontitis Seems to Be Linked to Increased IBD Disease Activity and Disability

/ Gorm Roager Madsen
ECCO24IBD Play the Video 4:05
Marc Ferrante

Mirikizumab As a Potential New Treatment in Patients with Crohn’s Disease

/ Marc Ferrante
CrohnsECCO24 Play the Video 8:36
Daniele Noviello

Risankizumab Downregulates IL-23-Induced Mucosal Pathogenic Th17 Cells in Patients with Crohn’s Disease

/ Daniele Noviello
CrohnsECCO24 Play the Video 5:49
Anja Poulsen

Colon Involvement or Isolated Small Intestinal Resection is Associated with a Higher Risk of Re-Resection in Crohn’s Disease Patients

/ Anja Poulsen
CrohnsECCO24 Play the Video 04:49
Joana Revés

No Association Between Bowel Damage and Disability in Patients with Recently Diagnosed Crohn’s Disease

/ Joana Revés
CrohnsECCO24 Play the Video 06:52
Back to top